GEN Exclusives

More »

GEN News Highlights

More »
Mar 3, 2009

Broad Institute Taps Complete Genomics to Further Cancer Biomarker Research

  • Complete Genomics will conduct complete human genome sequencing pilot studies of glioblastoma and melanoma for the Broad Institute. The company will sequence five genomes from samples provided by the institute.

    The first genome sequenced will be a test case that has already been studied extensively by the scientific community. The other four genomes are tumor and matched-pair normals; one pair will be used to study glioblastoma and the other melanoma.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Stopping Research Fraud

What is the best approach to curbing scientific misconduct and outright fraud?